HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$66.47
Day range
$64.50 - $66.25
Year range
$8.28 - $99.41
Market cap
7.13B USD
Avg Volume
5.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 29.28M | 44.38% |
Net income | -24.60M | -25.80% |
Net profit margin | — | — |
Earnings per share | -0.25 | 3.85% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 362.08M | 132.87% |
Total assets | 368.49M | 118.65% |
Total liabilities | 20.07M | -13.51% |
Total equity | 348.42M | — |
Shares outstanding | 100.49M | — |
Price to book | 19.10 | — |
Return on assets | -19.49% | — |
Return on capital | -20.36% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -24.60M | -25.80% |
Cash from operations | -17.64M | -61.45% |
Cash from investing | 35.73M | 392.19% |
Cash from financing | 188.00K | -98.25% |
Net change in cash | 18.33M | 153.75% |
Free cash flow | -8.50M | -112.70% |
About
CEO
Founded
2012
Website
Employees
27